Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Chevallard Daniel R. Create: Alert

All | News | Filings
Date FiledTypeDescription
05/16/2019 4/A Chevallard Daniel R. (CFO) has filed a Form 4 on Regulus Therapeutics Inc.
Txns: Granted 8,000 options to buy @ $0.95, valued at $7.6k

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy